GE HealthCare Technologies Inc.
GEHC
Clasificación en acciones
#773
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Precio por acción
$69.84
Capitalización bursátil
$31.55B
Cambio (1 día)
0.39%
Cambio (1 año)
-5.69%
País
US
Comercio GE HealthCare Technologies Inc. (GEHC)
Categoría
Healthcare
Margen Operativo de GE HealthCare Technologies Inc. (GEHC)
Margen Operativo al October 2026 TTM: 12.70%
Según los informes financieros más recientes y el precio de las acciones de GE HealthCare Technologies Inc., el margen operativo actual (TTM) es 12.70%. Al final de 2024, el margen operativo era 13.34%.
Historial de Margen Operativo de GE HealthCare Technologies Inc. desde 2019 hasta 2026
Margen Operativo al final de cada año
| Año | Margen Operativo | Cambiar |
|---|---|---|
| 2026 (TTM) | 12.70% | -4.30% |
| 2025 | 13.27% | -0.52% |
| 2024 | 13.34% | 7.15% |
| 2023 | 12.45% | -9.45% |
| 2022 | 13.75% | -13.47% |
| 2021 | 15.89% | 0.25% |
| 2020 | 15.85% | 24.12% |
| 2019 | 12.77% | 0.00% |
Margen Operativo de empresas similares o competidoras
| Empresa | Margen Operativo | Diferencia de Margen Operativo | País |
|---|---|---|---|
| 74.94% | -94.10% |
AU
|
|
| 3.33% | -99.74% |
US
|
|
| -19.76% | -101.56% |
US
|
|
| -14.33% | -101.13% |
US
|
|
| 0.00% | - |
US
|
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.